Clinical Trial Update: An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I) [Phase 1, Phase 2]

View source ↗

Summary

An extension study (JR-171-101) in patients with Mucopolysaccharidosis Type I has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis

Drugs mentioned

• JR-171

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis I | Phase 1, Phase 2 | Status: COMPLETED